
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia Inc. has demonstrated a strong financial performance, with total revenue per Accountable Healthcare System Client (AHSC) increasing to $25,300, marking a 5.4% year-on-year improvement primarily driven by the growth in Network Solutions. The company has successfully launched high-value products and added new AHSCs, resulting in a 20% rise in revenue opportunities year-on-year, while management anticipates further growth in total revenue per AHSC for FY26. Additionally, Phreesia has achieved a notable increase in free cash flow to $9.2 million, a significant turnaround from negative figures a year prior, alongside pro forma operating margins rising to 14.9%, reflecting strong incremental margins and effective revenue generation strategies.
Bears say
Phreesia Inc. faces a negative outlook due to several financial indicators and market conditions. The company's payment-facilitator volume percentage remained stagnant year-over-year at 82%, coupled with a declining take rate of 2.79%, which may signal diminishing pricing power or competitive pressures within its market segment. Additionally, the delay in achieving the $500 million run-rate revenue target from FY25 to FY26, attributed to a reevaluation of the capital markets and economic environment, raises concerns regarding growth sustainability and execution risk amid potential future declines in patient visit volumes linked to external factors such as COVID-19 surges.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares